Phase Weeks 1-2 Draw volume 7.5 units (0.075 mL) Total blend delivered ~2.0 mg total blend GHK-Cu ~1.25 mg KPV ~250 mcg BPC-157 ~250 mcg TB-500 ~250 mcg Phase Weeks 3-4 Draw volume 15 units (0.15 mL) Total blend delivered ~4.0 mg total blend GHK-Cu ~2.5 mg KPV ~500 mcg BPC-157 ~500 mcg TB-500 ~500 mcg Phase Weeks 5-8 Draw volume 22.5 units (0.225 mL) Total blend delivered ~6.0 mg total blend GHK-Cu ~3.75 mg KPV ~750 mcg BPC-157 ~750 mcg TB-500 ~750 mcg Phase Weeks 9-12 (taper) Draw volume 15 units (0.15 mL) Total blend delivered ~4.0 mg total blend GHK-Cu ~2.5 mg KPV ~500 mcg BPC-157 ~500 mcg TB-500 ~500 mcg Blend ratio 50 / 10 / 10 / 10 mg GHK-Cu dominant Select a draw volume from the titration table above to see the approximate amount of each peptide delivered
Targeted treatments, like growth hormone-releasing peptides including ipamorelin, can help support your hormone production and combat some aging changes
Use the included measuring scoop for accurate dosing
- Niacinamide 5%: tng cng kha nng chng oxy hoa, kim soat du nhn, h tr ngn nga tinh trang mun, lam thu nho l chn lng, y lui lao hoa, duy tri m cn thit trn da
The peptide promotes lipolysis without influencing broader GH effects such as IGF-1 stimulation
(preclinical GH axis studies)
